These final results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 help the idea of focusing on ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-related disorders. At that point, https://rufusw603eav2.wikidirective.com/user